References - Therapeutic Strategies in Cancer Biology and Pathology - page 241

Ravelli, A., Massobrio, M., Tesarik, J., 1998. Nongenomic actions of steroid hormones in
reproductive tissues. Endocrine. Rev. 19, 3-17.
Ravindranath, A., Yuen, H.F., Chan, K.K., Grills, C., Fennell, D.A., Lappin, T.R., et al., 2011.
Wnt-beta-catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin
expression in breast cancer. Br. J. Cancer 105, 542-551.
Rawson, J.B., Manno, M., Mrkonjic, M., Daftary, D., Dicks, E., Buchanan, D.D., et al., 2011.
Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing
tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis 32,
741-747.
Rayala, S.K., den Hollander, P., Manavathi, B., Talukder, A.H., Song, C., Peng, S., et al., 2006.
Essential role of KIBRA in co-activator function of dynein light chain 1 in mammalian
cells. J. Biol. Chem. 281, 19092-19099.
Rayner, K., Chen, Y.X, Hibbert, B., White, D., Miller, H., Postel, E.H., et al., 2007.
NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression
with progression of atherosclerosis. Am. J. Physiol. Regul. Integr. Com. Physiol. 292,
R743-750.
Rayner, K., Chen, Y.X., Hibbert, B., White, D., Miller, H., Postel, E.H., et al., 2008. Discovery
of NM23-H2 as an estrogen receptor beta-associated protein: role in estrogen-induced
gene transcription and cell migration. J. Steroid. Biochem. Mol. Biol. 108, 72-81.
Recino, A., Sherwood, V., Flaxman, A., Cooper, W.N., Latif, F., Ward, A., et al., 2010. Human
RASSF7 regulates the microtubule cytoskeleton and is required for spindle formation, Aurora
B activation and chromosomal congression during mitosis. Biochem. J. 430, 207-213.
Reeves, M.E., Baldwin, S.W., Baldwin, M.L., Chen, S., Moretz, J.M., Aragon, R.J., et al.,
2010. Ras-association domain family 1C protein promotes breast cancer cell migration
and attenuates apoptosis. BMC Cancer 10, 562.
Reifenberger, J., Knobbe, C.B., Sterzinger, A.A., Blaschke, B., Schulte, K.W., Ruzicka, T.,
et al., 2004. Frequent alterations of Ras signaling pathway genes in sporadic malignant
melanomas. Int. J. Cancer 109, 377-384.
Reis, S., Pontes Jr., J., Antunes, A.A., Dall'Oglio, M.F., Dip, N., Passerotti, C.C., 2012. Mir-
21 may act as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in
prostate cancer. BMC Urology. 12, 14.
Reiter, E., Lefkowitz, R.J., 2006. GRKs and b-arrestins: roles in receptor silencing, trafcking
and signalling. Trends. Endocrinol. Metab. 17, 159-165.
Ren, H.Z., Pan, G.Q., Wang, J.S., Wen, J.F., Wang, K.S., Luo, G.Q., et al., 2010a. Reduced
stratifin expression can serve as an independent prognostic factor for poor survival in
patients with esophageal squamous cell carcinoma. Dig. Dis. Sci. 55, 2552-2560.
Ren, Y., Zhou, X., Mei, M., Yuan, X.B., Han, L., Wang, G.X., et al., 2010b. MicroRNA-21
inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-
wild type) to taxol. BMC Cancer 10, 27.
Ren, Y., Cheung, H.W., von Maltzhan, G., Agrawal, A., Cowley, G.S., Weir, B.A., et al., 2012.
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer
oncogene ID4. Sci. Transl. Med. 4, 147ra112.
Renault, M.A., Roncalli, J., Tongers, J., Misener, S., Thorne, T., Jujo, K., et al., 2009. The
Hedgehog transcription factor Gli3 modulates angiogenesis. Circ. Res. 105, 818-826.
Richardson, D.R., 2005. Molecular mechanisms of iron uptake by cells and the use of iron
chelators for the treatment of cancer. Curr. Med. Chem. 12, 2711-2729.
Richardson, D.R., Sharpe, P.C., Lovejoy, D.B., Senaratne, D., Kalinowski, D.S., Islam, M.,
et al., 2006. Dipyridyl thiosemicarbazone chelators with potent and selective antitumor
activity form iron complexes with redox activity. J. Med. Chem. 49, 6510-6521.